Historical data

OTHER2 trials

Sponsors

CytoDyn, Inc., Mylan (Taiwan) Ltd

Conditions

Chronic Hepatitis B InfectionHIVHuman Immunodeficiency Virus

Phase 2

Treatment Substitution With PRO 140 Monotherapy in Adult Subjects With HIV-1 Infection

CompletedNCT02175680

CytoDyn, Inc.HIV, Human Immunodeficiency Virus

Start: 2014-04-16End: 2015-02-02Updated: 2023-04-14

Phase 4

Efficacy and Safety of Ricovir® in Maintaining Durability of Viral Response in Chronic Hepatitis B Patients Who Have Been Treated With Viread® and Have Undetectable HBV DNA in Serum

CompletedNCT05355467

Mylan (Taiwan) LtdChronic Hepatitis B Infection

Start: 2019-08-21End: 2021-07-13Updated: 2022-05-02

Related Papers

Suppression of human and simian immunodeficiency virus replication with the CCR5-specific antibody Leronlimab in two species

PLoS Pathogens2022-03-3115 citations